PSNL - Personalis, Inc.

QQQ $ 601.61 $ -4.52 (-0.75 %)

DIA $ 465.68 $ -5.27 (-1.12 %)

SPY $ 664.21 $ -5.52 (-0.82 %)

TLT $ 89.13 $ 0.04 (0.05 %)

GLD $ 370.70 $ -3.33 (-0.89 %)

Previous Close

$ 7.51

Open

$ 7.37

Bid

$ 7.45 x 102

Ask

$ 7.47 x 1,407

Day's Range

$ 7.33 - $ 7.73

52 Week Range

$ 2.83 - $ 10.95

Volume

1,126,932

Average Volume

Market Cap

666.92M

Beta (5Y Monthly)

$ 1.92

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-04-2025	09-30-2025	10-Q
2	08-05-2025	06-30-2025	10-Q
3	05-06-2025	03-31-2025	10-Q
4	02-27-2025	01-01-1970	10-K
5	11-06-2024	09-30-2024	10-Q
6	08-07-2024	06-30-2024	10-Q
7	05-08-2024	03-31-2024	10-Q
8	02-28-2024	12-31-2023	10-K
9	11-07-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-03-2023	03-31-2023	10-Q
12	02-23-2023	12-31-2022	10-K
13	11-02-2022	09-30-2022	10-Q
14	08-03-2022	06-30-2022	10-Q
15	05-04-2022	03-31-2022	10-Q
16	02-24-2022	12-31-2021	10-K
17	11-04-2021	09-30-2021	10-Q
18	08-04-2021	06-30-2021	10-Q
19	05-05-2021	03-31-2021	10-Q
20	02-25-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	08-06-2020	06-30-2020	10-Q
23	05-07-2020	03-31-2020	10-Q
24	03-25-2020	12-31-2019	10-K
25	11-13-2019	09-30-2019	10-Q
26	08-13-2019	06-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Morgan Stanley Maintains Equal-Weight on P...
11/11/2025 16:54:37

Morgan Stanley analyst Tejas Savant maintains Personalis (NASDAQ:PSNL) with a Equal-Weight and raises the price target from ...

Guggenheim Maintains Buy on Personalis, Ra...
11/11/2025 13:57:09

Guggenheim analyst Subbu Nambi maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price target from $6 to $12.

HC Wainwright & Co. Maintains Buy on Perso...
11/11/2025 12:10:30

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price ta...

BTIG Maintains Buy on Personalis, Raises P...
11/11/2025 10:36:47

BTIG analyst Mark Massaro maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price target from $11 to $12.

pagaya-technologies-posts-upbeat-q3-results-joins-ironwood-pharmaceuticals-treehouse-foods-and-other-big-stocks-moving-higher-on-monday

Pagaya Technologies Posts Upbeat Q3 Result...
11/10/2025 15:01:52

Personalis Announces Medicare Coverage Of ...
11/10/2025 14:07:49

HC Wainwright & Co. Maintains Buy on Perso...
11/06/2025 12:08:39

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price ta...

Needham Maintains Buy on Personalis, Raise...
11/05/2025 11:37:24

Needham analyst Mike Matson maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price target from $7 to $10.

Personalis Lowers FY2025 Sales Guidance fr...
11/04/2025 21:03:05

Personalis (NASDAQ:PSNL) lowers FY2025 sales outlook from $70.000 million-$80.000 million to $68.000 million-$73.000 million vs...

Personalis Sees Q4 Sales $15.700M-$20.700M...
11/04/2025 21:02:35

Personalis (NASDAQ:PSNL) sees Q4 sales of $15.700 million-$20.700 million vs $21.769 million analyst estimate.

Personalis Q3 EPS $(0.24) Beats $(0.28) Es...
11/04/2025 21:01:58

Personalis (NASDAQ:PSNL) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.28) by...

Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

BTIG Maintains Buy on Personalis, Raises P...
10/22/2025 12:16:03

BTIG analyst Mark Massaro maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price target from $6 to $11.

Personalis Announces Phase 3 LAURA Trial D...
10/16/2025 13:08:22

Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, announced new data from an AstraZeneca ph...

Personalis And Yale Cancer Center Collabor...
09/10/2025 20:10:39

HC Wainwright & Co. Reiterates Buy on Pers...
09/08/2025 10:58:41

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Personalis (NASDAQ:PSNL) with a Buy and maintains $8.5 pri...

Personalis Announces New Data From Astraze...
09/03/2025 20:19:09

Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, announced new data from an AstraZeneca ph...

Personalis Expands VA Million Veteran Prog...
08/22/2025 11:03:40

12 Health Care Stocks Moving In Wednesday'...
08/06/2025 17:06:59

HC Wainwright & Co. Maintains Buy on Perso...
08/06/2025 12:44:20

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Personalis (NASDAQ:PSNL) with a Buy and lowers the price ta...